Neuro Care

What Neuro Care does

Neurocare, Inc. is a Massachusetts-based sleep disorder diagnostic company founded in 1988 that delivers in-lab polysomnography (PSG), split-night studies, PAP titration, Multiple Sleep Latency Tests (MSLT), and Home Sleep Apnea Testing (HSAT) using Phillips NightOne portable devices distributed via UPS. The company operates three AASM-accredited owned sleep centers (Newton, Brockton, Beverly) and provides testing services through seven hospital partnership locations across Massachusetts and New Hampshire, including Beth Israel Deaconess, Brigham and Women's Faulkner, Emerson Hospital, Massachusetts Eye and Ear, Parkland Medical Center, and Milford Regional. It also operates the Neurocare Center for Research, a clinical trials division that has completed over 80 trials in the past decade in collaboration with Board-Certified Principal Investigator Robert Thomas, MD, including a Phase 3/4 study with Jazz Pharmaceuticals on XYWAV for narcolepsy.

The company's go-to-market is B2B2C: referring physicians and healthcare providers direct patients to Neurocare via the oneForm digital referral and precertification system and the IndigoArc Sleep physician portal, with services billed primarily through insurance to a broad payor panel (Harvard Pilgrim, BCBS, United Healthcare, Aetna, Medicare, Cigna, Tufts, Fallon, Neighborhood Health Plan, Unicare/GIC, MassHealth ACOs). Patients remain responsible for deductibles and copays. The company also offers specialized pediatric and adolescent sleep testing across multiple age tiers (3-17 depending on location) and Spanish-language support via bilingual staff and a language line.

Neurocare is a privately held, founder- or independent-owned entity headquartered at 70 Wells Avenue, Newton, MA, with no disclosed venture capital, private equity, or institutional ownership. It maintains HIPAA-compliant medical records handling, AASM accreditation, and an AdvancedMD patient payment portal. The company employs between 51 and 100 people and operates solely within Massachusetts and New Hampshire, generating revenue through professional-services billing for diagnostic testing and clinical research activities.

Name

Neuro Care

Legal name

Neurocare, Inc.

Website

https://neurocareinc.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

51–100 employees

Short description

Neurocare, Inc. is a Massachusetts-based sleep disorder diagnostic company operating AASM-accredited centers and hospital partnerships that deliver in-lab and home sleep testing, pediatric sleep studies, and clinical research services across Massachusetts and New Hampshire.

Ownership category

akta.pro rank

Product category

Sleep Diagnostics Services

NAICS

Home Health Equipment Rental (532283)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Home Health Care Services (8082)

akta.pro primary industry

Sleep Diagnostic Centers (Polysomnography) (HLAFAKAF)

akta.pro secondary industries

Ambulatory Sleep Medicine Centers (HLAFABAJ), Sleep Medicine Clinic (HLAKANAB), Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)

Keywords

• Sleep diagnostic testing
• Polysomnography services
• Home sleep apnea testing
• Sleep center operations
• Clinical sleep research

Headquarters

HQ city

Newton

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Sleep Diagnostic Testing Services: Revenue generated from conducting in-lab sleep studies (polysomnography, split night studies, PAP titration) and home sleep apnea testing (HST). Services are billed to insurance providers with patient responsibility for deductibles, co-pays, and non-covered portions.
2. Clinical Research Services: Revenue from conducting clinical trials for pharmaceutical companies evaluating investigational medications and devices for sleep disorders.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Neurocare operates accredited sleep centers that provide diagnostic testing for sleep disorders, including in-lab polysomnography, split-night studies, PAP titration, multiple sleep latency tests, and home sleep apnea testing (HSAT). The company also runs a clinical research division (Neurocare Center for Research) conducting investigational medication and device trials for sleep conditions, delivering services through physician referrals across Massachusetts and New Hampshire.

Product overview

Neuro Care operates as a sleep disorder diagnostic and management company offering a unified portfolio of testing services. The core offerings include Home Sleep Testing (HST) for at-home diagnosis of obstructive sleep apnea using portable devices, and Sleep Center Testing (in-lab studies) providing Polysomnogram (PSG), Split Night Study, PAP Titration, and Multiple Sleep Latency Test (MSLT). Specialized Child and Teen Testing services are available at select locations. The company provides supporting services including Sleep Education resources, a Physician Portal for clinical data access, and Precertification assistance for insurance authorization. Through the Neurocare Center for Research, the company also conducts clinical trials for investigational sleep medications and devices. Sleep disorder diagnoses cover Obstructive Sleep Apnea, Restless Leg Syndrome, Periodic Limb Movement Disorder, and Narcolepsy. Services are delivered at company-owned facilities in Newton, Brockton, and Beverly, MA, as well as through partnerships with multiple hospital systems across Massachusetts and New Hampshire.

Differentiator

Problem solved

Functional benefit

Products and services

• Home Sleep Testing (HST) Portable diagnostic service enabling patients to test for Obstructive Sleep Apnea (OSA) at home using a chest belt, finger sensor, and nasal cannula to monitor breathing, oxygen saturation, pulse rate, and airway blockages.
• Sleep Center Testing (In-Lab) In-laboratory sleep studies including Polysomnogram (PSG), Split Night Study, PAP Titration Study, and Multiple Sleep Latency Test (MSLT), performed with technologist monitoring in private bedroom settings.
• Child and Teen Testing Specialized sleep testing services designed for children and adolescents, with age-appropriate facilities and protocols available at select Neurocare locations (ages 3+ to 15+ depending on site).
• Neurocare Center for Research Clinical research services conducting investigational medication and device trials for sleep disorders, with over 80 completed trials and 50+ years of combined clinical trials experience among research staff.
• Sleep Disorders Diagnosis Diagnostic evaluation services for Obstructive Sleep Apnea, Restless Leg Syndrome, Periodic Limb Movement Disorder, and Narcolepsy, enabling proper diagnosis and downstream treatment planning.
• Precertification Services Insurance precertification and prior authorization management that facilitates study approval through submission and coordination with payors including MassHealth ACOs, supporting both providers and patients.

Quantifiable outcome

• Successfully completed more than 80 clinical trials in the past decade
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

15 partnerships are on record, tiered core and minor.

• Academic Medical Centers and Community HospitalscoreStrategic or Co-development PartnerNeurocare collaborates with academic medical centers and community hospitals to design and manage sleep disorder programs. This partnership enables access to broader patient populations and clinical expertise.
• Beth Israel Deaconess Hospital - NeedhamcoreStrategic or Co-development PartnerHospital partnership providing sleep center testing, home sleep testing, and child/teen testing (ages 15+) at the Needham, MA location.
• Beth Israel Deaconess Hospital - MiltoncoreStrategic or Co-development PartnerHospital partnership offering sleep center testing and home sleep testing at the Milton, MA location.
• Brigham and Women's Faulkner HospitalcoreStrategic or Co-development PartnerHospital partnership providing sleep center testing and home sleep testing at the Boston, MA location.
• Emerson HospitalcoreStrategic or Co-development PartnerHospital partnership offering sleep center testing, child/teen testing (ages 4+), and home sleep testing at the Concord, MA location.
• Massachusetts Eye and Ear - QuincycoreStrategic or Co-development PartnerHospital partnership providing sleep center testing and child/teen testing (ages 4+) at the Quincy, MA location.
• Parkland Medical CentercoreStrategic or Co-development PartnerHospital partnership offering sleep center testing and child/teen testing (ages 8+) at the Derry, NH location.
• Milford Regional Sleep CentercoreStrategic or Co-development PartnerPartnership providing sleep center testing and child/teen testing (ages 13+) at the Milford, MA location.
• Harvard Pilgrim Health CarecoreOthersInsurance payor contracted for sleep testing services.
• Blue Cross Blue ShieldcoreOthersInsurance payor contracted for sleep testing services.
• United HealthcarecoreOthersInsurance payor contracted for sleep testing services.
• AetnacoreOthersInsurance payor contracted for sleep testing services.
• MedicarecoreOthersMedicare coverage for eligible sleep testing services.
• Robert Thomas, MDcoreStrategic or Co-development PartnerBoard Certified, Boston-based sleep physician serving as Principal Investigator for selected clinical trials at Neurocare Center for Research. Collaboration produces patient-focused, high quality results.
• Jazz PharmaceuticalsminorStrategic or Co-development PartnerCurrently conducting Phase 3/4 clinical trials evaluating XYWAV for narcolepsy and idiopathic hypersomnia patients.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• VirtuOx: Independent home sleep testing provider with a physician-referred diagnostic model and national footprint; comparable to Neurocare's HST program and B2B2C referral channels.
• SleepMed Inc. National sleep diagnostic services company operating in-lab PSG and HSAT programs with strong hospital partnership and referral model - directly comparable to Neurocare's diagnostic and physician-referral approach.
• SleepQuest: Independent home sleep testing and PAP setup provider with a physician-referred model and insurance billing; closely comparable to Neurocare's HST and referral-driven service model.

Broad incumbents

• Philips Respironics: Major sleep and respiratory manufacturer providing PSG, HSAT (NightOne), and PAP equipment used by Neurocare; comparable as the incumbent supplier of the diagnostic hardware that Neurocare operates.
• ResMed: Global leader in sleep apnea devices and connected health; comparable in that patients diagnosed at Neurocare often transition onto ResMed PAP therapy, making it a downstream incumbent in the same clinical pathway.
• Apria Healthcare (Owens & Minor Patient Direct): Large national home medical equipment and sleep therapy provider; comparable as a broader sleep/respiratory services incumbent, though larger and more diversified than Neurocare.

Emerging players

• Itamar Medical (WatchPAT): Provider of WatchPAT home sleep apnea testing devices used by Neurocare and similar diagnostic programs; comparable as an enabling/adjacent technology supplier in the HSAT ecosystem.
• BetterNight: Multi-state virtual and in-person sleep diagnostic provider offering HSAT, in-lab PSG, and tele-sleep consultations; comparable as a regional operator expanding in the same sleep diagnostic niche.

Others

• Mass Eye and Ear (MEEI): Hospital partner of Neurocare operating a sleep testing site in Quincy; comparable as a regional specialty hospital that both competes for and partners with Neurocare in delivering sleep diagnostics.
• Jazz Pharmaceuticals (clinical trial sponsor): Pharmaceutical sponsor currently running narcolepsy trials at Neurocare's research center; comparable as an ecosystem participant paying Neurocare for clinical trial services rather than competing for diagnostic patients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/neurocaresleep

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neuro Care